BBIBP-CorV

BIOLOGICAL2 trials

Sponsors

Royal College of Surgeons in Ireland - Medical University of Bahrain, ANRS, Emerging Infectious Diseases

Conditions

COVID-19Covid19Healthy VolunteerSARS-CoV 2 InfectionSars-CoV-2 InfectionVaccine Adverse Reaction

Phase 2

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Active, not recruitingNCT05409300

ANRS, Emerging Infectious DiseasesCOVID-19, Healthy Volunteer, Sars-CoV-2 Infection +1

Start: 2022-04-25End: 2025-02-28Updated: 2024-03-27

Unknown Phase

Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain

CompletedNCT04993560

Royal College of Surgeons in Ireland - Medical University of BahrainCovid19, SARS-CoV 2 Infection

Start: 2021-07-18End: 2021-10-19Updated: 2021-10-26

Related Papers

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.

2023-11-277 citations

Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.

2023-01-2318 citations